FLS play a central role in RA pathogenesis and are emerging as attractive therapeutic targets.[9, 19] In the present study, we demonstrated for the first time that the “regulatory” phenotype of FLS (FLSreg) can be induced in vitro by using IFN‐γ plus rapamycin. This evidence concerns the gene IFNG and rheumatoid arthritis.